Surgery Godfather Chapter 1777 - Capítulo 1777: 1259: Blooming Everywhere

Capítulo 1777: Chapter 1259: Blooming Everywhere

Although there might still be minute differences in absolute surface accuracy and transmittance of the lenses compared to the top imported products, which may not be noticeable to the naked eye but can be asured by instrunts, the entire optical module, integrated with self-developed intelligent image algorithms, optimized structural design, and localized precision manufacturing processes, has its comprehensive performance indicators, after preliminary testing, already sufficient, or even surpassing in certain paraters, to et the most rigorous observational needs of Yang Ping’s research team for this equipnt.

President Wang gently stroked the prototype that had just rolled off the line, gleaming with a cold tallic luster and having an internal structure as precise as a work of art, overwheld with excitent, his voice choked.

…

anwhile, President Li, focused on high-end biochemical reagents, also welcod his “dream team,” instantly propelling his company, which was previously focused on the mid-to-low-end market, to the forefront of biotechnology.

Leading the team was Susan Chen, an Arican-Chinese female scientist with a poised deanor and sharp insight. She had led multiple key enzy preparation projects at the world’s largest reagent company, rck Millipore, covering strain construction, ferntation optimization, and purification processes, with profound experience across the entire chain.

However, as a Chinese descendant, after being promoted to Senior Director, she clearly felt the existence of an invisible “glass ceiling,” with many core strategic decisions and cutting-edge project resources being inaccessible to her. She always harbored a sense of unfulfillnt and complex emotions towards her cultural roots.

When the “Breaking Wall” initiative called through the overseas talent network, she barely hesitated before declining her company’s invitation to stay, resigning from an enviable position, and returning to her country with a hard drive encrypted with twenty years’ worth of accumulated key experintal data and core technological ideas.

Joining her in settling into Dai Biotech were several young doctors returning from giants like Thermo Fisher Scientific and Bio-Tech. They did not disdain the relatively rudintary laboratory conditions and the scale limitations of the pilot plant but instead imdiately engaged in the urgent research on several “specialty enzys” critical to Yang Ping’s project’s progress and constrained by patent barriers.

Susan Chen did not simply repeat her work abroad, trying to replicate or imitate the process routes of imported products. She astutely pointed out, “President Li, we can’t keep following behind others, looking for gaps in their patent jungle. Their patent barriers are too high, and many are based on specific host strains or purification dia that we cannot bypass. We must find a completely new, our own technical path.”

She led the team to first conduct a reverse analysis of imported reagents, precisely analyzing their performance bottlenecks and potential defects.

Then, combined with the latest research achievents in synthetic biology, yeast surface display, and protein directed evolution in China, they pioneered a new rational enzy molecule design and efficient expression and purification integration process.

They screened a bank of dostically constructed engineering strains, and with the help of Doctor Chen Xiao from Massachusetts Institute of Technology, used advanced gene editing tools to direct the evolution of the enzy molecules, making them more suitable for efficient expression in a more cost-effective, scalable ferntation system.

At the sa ti, they developed a new “one-step thod” purification strategy based on novel affinity chromatography dia, abandoning several expensive and controlled imported resins relied upon in the import process.

This completely new process, although initially appearing costly due to the need to optimize many paraters, boasts revolutionary benefits: it completely bypasses the patent blockade of international giants, with all intellectual property rights entirely independent; the produced enzy preparations, when tested repeatedly for heat activity and long-term storage stability, surprisingly exhibit potentials not inferior to, or even surpassing in certain key indicators, import products.

“President Li, look,” Susan pointed at the steep and symtric purity peak curve on the high-performance liquid chromatography screen, unable to hide her excitent, “This is the data from our thirty-seventh batch of small-scale products, with purity stabilized above 99.8%. Most importantly, those protease impurities and nucleic acid residues that could easily affect subsequent experints are an order of magnitude lower than imported products. This ans that for the most precise cellular experints and molecular interaction detections by Professor Yang’s team, background interference will be lesser, with significantly improved data reliability and reproducibility!”

President Li looked at the awe-inspiring data previously only seen on the instruction manuals of top imported reagents, his hands trembling with excitent as if he were holding priceless treasures.

He knew deeply that this was not rely a breakthrough in several critical reagents solving the current urgent need; it also ant that his Dai Technology had found a potential path to break free from low-level repetition and achieve original innovation and high-end breakthroughs, opening up brand new imaginative space for the company’s future developnt.

As a family company, he felt fortunate to have joined the “Wall-breaking Alliance,” otherwise he never would have such opportunities for technological leaps.

He imdiately ordered the concentration of all advantageous resources of the company to fully cooperate with Susan and Chen Xiao’s team for process scaling and stability verification, sparing no expense to stably produce this batch of enzys condensed with efforts and wisdom in the shortest ti, delivering them to Yang Ping’s laboratory.

…

anwhile, at President Zhang’s company in charge of research and developnt—Xunkai Software, the change was even more “groundbreaking.”

President Zhang, originally from a technical background, was quite proud of the company’s existing data interface and basic analysis software, but he found that the “experts” he recruited had thought patterns, technical visions, and architecture capabilities that completely exceeded his previous understanding.